2 enrolling by invitation. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Enrolling by invitation 2 |
Follow Lymphoproliferative Disorders: new trials by email Literature Review of Lymphoproliferative Disorders trials Research Report on Lymphoproliferative Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma R-CHOP, Decitabine in combination with R-CHOP - Lymphoma, Large-Cell, Diffuse | Phase 3 | Enrolling by invitation | Second Affiliated Hospital of Nanchang University | 80 | 2024-07-01 | 2026-01-16 |
| BrEto-TCL - Defining the Role of Brentuximab and Etoposide for Optimizing First-line Therapy of T-cell Lymphomas Doxorubicin, Vincristine, Etoposide - Peripheral T-cell Lymphoma | Phase 3 | Enrolling by invitation | N.N. Petrov National Medical Research Center of Oncology | 114 | 2013-10-01 | 2025-12-02 |
Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, T-Cell, Peripheral (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Lymphoma, B-Cell (1) · Lymphoma, T-Cell (1)
Brentuximab Vedotin (1) · Cyclophosphamide (1) · Decitabine (1) · Doxorubicin (1) · Etoposide (1) · Prednisone (1) · R-CHOP protocol (1) · Vincristine (1)
N.N. Petrov National Medical Research Center of Oncology (1) · Second Affiliated Hospital of Nanchang University (1)
China (1)